Celosome MID

Here is a 310-word description of  Celosome MID :

Celosome MID : Injectable PCL Microsphere Collagen Biostimulator

**Celosome MID**, developed by **NOVU Science** (South Korea), is an **injectable dermal biostimulator** leveraging the same core biocompatible polymer technology as its solid counterpart (Celosome IMPLANT) but in a microsphere suspension format. Its active component is **Polycaprolactone (PCL) microspheres** (approximately 20-50 microns in diameter), suspended in a carrier gel. PCL is a well-established, synthetic, biodegradable polymer renowned for its exceptional longevity and biocompatibility in medical applications.https://skin-reboot.com/

**Mechanism of Action (Neocollagenesis & Scaffolding):**
Upon injection, the PCL microspheres disperse within the target tissue (typically the deep dermis or subcutaneous layer). These microspheres function as a **long-lasting, three-dimensional scaffold**. They immediately provide subtle structural support while triggering a controlled inflammatory response. This attracts fibroblasts, the body’s collagen-producing cells, to the area. Over time, fibroblasts deposit new **Type I and Type III collagen** around the microspheres. Crucially, PCL degrades *very* slowly via hydrolysis, maintaining its structural integrity for **approximately 24-36 months**. During this extended period, it continuously stimulates collagen production. As the microspheres finally bioderade into harmless byproducts (caproic acid) eliminated naturally, the newly formed, dense collagen network remains, providing sustained volumization and skin quality improvement.

**Key Features & Benefits:**
* **Long-Duration Collagen Biostimulation:** Continuous neocollagenesis over 2-3+ years due to PCL’s slow degradation.
* **Natural-Looking Volumization & Lift:** Gradual build-up of autologous collagen provides natural tissue restoration and subtle structural support/lift.
* **Skin Quality Enhancement:** Significantly improves skin **elasticity, firmness, texture, and hydration** through sustained collagen and extracellular matrix renewal.
* **Biocompatible & Safe Profile:** PCL has decades of safety history in absorbable medical devices.
* **Minimal Swelling Post-Treatment:** Typically associated with less edema than large-volume HA fillers or PLLA.
* **Versatility:** Suitable for treating areas requiring both volumization and skin rejuvenation.

**Primary Indications:**
* Correction of **moderate to severe facial wrinkles and folds** (e.g., nasolabial folds, marionette lines).
* Restoration of **facial volume loss** in cheeks, temples, and jawline.
* Improvement of overall **facial contour** and definition.
* Enhancement of **skin laxity, texture, and elasticity**.
* **Hand rejuvenation** (volume restoration and skin quality).

**Administration & Critical Considerations:**
* **Expert Injection Essential:** **Must be administered only by physicians** highly skilled in advanced injection techniques, facial anatomy, and biostimulator properties. Precise depth (mid to deep dermis/subcutaneous) is critical to avoid visibility or nodules.
* **Pre-treatment Preparation:** Supplied as a prefilled syringe. Requires thorough mixing/kneading at room temperature before use to ensure uniform microsphere suspension. Do not dilute.
* **Technique:** Typically deposited using linear threading, fanning, or bolus techniques depending on the target area and desired effect.
* **Treatment Protocol:** Often involves **1-2 treatment sessions** initially, with optimal collagen build-up visible after 3-6 months. Results are long-lasting, with potential maintenance after 2+ years. “Tweaking” with HA filler can be done concurrently if needed.
* **Post-Treatment:** Mild redness, swelling, bruising, or tenderness at injection sites is common and transient. Gentle massage may be recommended post-injection to ensure even distribution.
* **Potential Adverse Events:** Includes nodules or granulomas (if injected too superficially or unevenly distributed), asymmetry, infection, or vascular compromise (extremely rare with proper technique). Delayed inflammatory reactions are possible but less common than with PLLA.
* **Not for Instant Volume:** Primary effect is collagen stimulation; immediate volumization is subtle. Manage patient expectations accordingly.
* **Regulatory Status:** Approved in various markets (e.g., KFDA, CE mark). Verify local approvals.

Celosome MID offers a unique long-duration solution bridging volumization and skin rejuvenation through sustained PCL-mediated collagen biostimulation, demanding injector expertise for optimal safety and outcomes.CONTACT US